Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

drug approval

  1. H

    India’s Generic Semaglutide Market Faces Branding Dispute

    Dr. Reddy’s to Rename Semaglutide Drug Following Court Concerns Brand Name Change Underway New Delhi – Dr. Reddy’s Laboratories informed the Delhi High Court on Friday that it intends to change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’. This decision follows a judge’s...
    • Himanshu
    • Thread
    • brand name change diabetes dr. reddy's laboratories drug approval generic drugs glp-1 receptor agonist india legal dispute novo nordisk olymra olymviq ozempic pharmaceuticals semaglutide type 2 diabetes
    • Replies: 0
    • Forum: Business
  2. K

    Lupin Secures USFDA Approval for Generic Brivaracetam Oral Solution, Launches in US Market

    Lupin Receives USFDA Nod for Seizure Treatment Drug Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
    • Karthik
    • Thread
    • anda brivaracetam briviact bse drug approval generic medication india lupin oral solution pharmaceutical industry pharmaceutical sales seizures us market usfda
    • Replies: 0
    • Forum: Business
Back
Top